CHASE INVESTMENT COUNSEL CORP – Regeneron Pharmaceuticals, Inc. Transaction History
CHASE INVESTMENT COUNSEL CORP portfolio value:
$0
portfolio value
CHASE INVESTMENT COUNSEL CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -798 shares | -471K | $688.87 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -86K | $591.13 | 798 | |
| Q1 2022 | share | 0.00% | 0 shares | 54K | $698.42 | 798 | |
| Q4 2021 | share | Increase | 0.00% | 798 shares | 503K | $642.51 | 798 |
| Q1 2021 | share | Decrease | -100.00% | -1.60K shares | -775K | $473.14 | 0 |
| Q4 2020 | share | Decrease | -69.90% | -3.73K shares | -2.21M | $483.11 | 1.60K |
| Q3 2020 | share | Decrease | -8.39% | -489 shares | -646K | $559.78 | 5.33K |
| Q2 2020 | share | Decrease | -18.60% | -1.33K shares | 138K | $623.65 | 5.82K |
| Q1 2020 | share | Increase | 0.00% | 7.15K shares | 3.49M | $488.29 | 7.15K |